Logo image of ALX.AS

ALUMEXX N.V. (ALX.AS) Stock Fundamental Analysis

Europe - AMS:ALX - NL0012194724 - Common Stock

1.43 EUR
-0.01 (-0.69%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

3

ALX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 23 industry peers in the Building Products industry. ALX has a medium profitability rating, but doesn't score so well on its financial health evaluation. ALX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALX had positive earnings in the past year.
ALX had a positive operating cash flow in the past year.
In the past 5 years ALX has always been profitable.
Of the past 5 years ALX 4 years had a positive operating cash flow.
ALX.AS Yearly Net Income VS EBIT VS OCF VS FCFALX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M 4M

1.2 Ratios

ALX has a Return On Assets of 1.73%. This is in the lower half of the industry: ALX underperforms 60.87% of its industry peers.
With a decent Return On Equity value of 13.10%, ALX is doing good in the industry, outperforming 69.57% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.28%, ALX is doing worse than 60.87% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALX is significantly below the industry average of 10.74%.
Industry RankSector Rank
ROA 1.73%
ROE 13.1%
ROIC 5.28%
ROA(3y)2.13%
ROA(5y)5.77%
ROE(3y)8.96%
ROE(5y)14.03%
ROIC(3y)5.36%
ROIC(5y)9.33%
ALX.AS Yearly ROA, ROE, ROICALX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a Profit Margin value of 1.64%, ALX is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ALX has declined.
ALX has a Operating Margin (6.60%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ALX has grown nicely.
ALX's Gross Margin of 52.96% is fine compared to the rest of the industry. ALX outperforms 78.26% of its industry peers.
ALX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.6%
PM (TTM) 1.64%
GM 52.96%
OM growth 3Y1.92%
OM growth 5Y7.99%
PM growth 3Y-30.96%
PM growth 5Y-8.74%
GM growth 3Y26.81%
GM growth 5Y20.74%
ALX.AS Yearly Profit, Operating, Gross MarginsALX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALX is destroying value.
The number of shares outstanding for ALX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALX has more shares outstanding
The debt/assets ratio for ALX has been reduced compared to a year ago.
ALX.AS Yearly Shares OutstandingALX.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALX.AS Yearly Total Debt VS Total AssetsALX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 1.05, we must say that ALX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALX (1.05) is worse than 82.61% of its industry peers.
ALX has a debt to FCF ratio of 5.87. This is a neutral value as ALX would need 5.87 years to pay back of all of its debts.
ALX has a Debt to FCF ratio (5.87) which is in line with its industry peers.
A Debt/Equity ratio of 4.51 is on the high side and indicates that ALX has dependencies on debt financing.
The Debt to Equity ratio of ALX (4.51) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.51
Debt/FCF 5.87
Altman-Z 1.05
ROIC/WACC0.93
WACC5.65%
ALX.AS Yearly LT Debt VS Equity VS FCFALX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.75 indicates that ALX should not have too much problems paying its short term obligations.
ALX's Current ratio of 1.75 is fine compared to the rest of the industry. ALX outperforms 73.91% of its industry peers.
ALX has a Quick Ratio of 1.75. This is a bad value and indicates that ALX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALX (0.37) is worse than 86.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.37
ALX.AS Yearly Current Assets VS Current LiabilitesALX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

5

3. Growth

3.1 Past

ALX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 500.00%, which is quite impressive.
ALX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 50.47% yearly.
Looking at the last year, ALX shows a quite strong growth in Revenue. The Revenue has grown by 12.90% in the last year.
ALX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.03% yearly.
EPS 1Y (TTM)500%
EPS 3Y12.55%
EPS 5Y50.47%
EPS Q2Q%-105.14%
Revenue 1Y (TTM)12.9%
Revenue growth 3Y80.47%
Revenue growth 5Y76.03%
Sales Q2Q%-6.75%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALX.AS Yearly Revenue VS EstimatesALX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2

4. Valuation

4.1 Price/Earnings Ratio

ALX is valuated quite expensively with a Price/Earnings ratio of 35.75.
Compared to the rest of the industry, the Price/Earnings ratio of ALX is on the same level as its industry peers.
When comparing the Price/Earnings ratio of ALX to the average of the S&P500 Index (27.90), we can say ALX is valued slightly more expensively.
Industry RankSector Rank
PE 35.75
Fwd PE N/A
ALX.AS Price Earnings VS Forward Price EarningsALX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALX is valued a bit cheaper than 73.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.24
EV/EBITDA 6.25
ALX.AS Per share dataALX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALX!.
Industry RankSector Rank
Dividend Yield N/A

ALUMEXX N.V.

AMS:ALX (10/6/2025, 7:00:00 PM)

1.43

-0.01 (-0.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners60.78%
Ins Owner ChangeN/A
Market Cap10.01M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 35.75
Fwd PE N/A
P/S 0.26
P/FCF 2.24
P/OCF 2.01
P/B 2.04
P/tB N/A
EV/EBITDA 6.25
EPS(TTM)0.04
EY2.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.64
FCFY44.64%
OCF(TTM)0.71
OCFY49.72%
SpS5.59
BVpS0.7
TBVpS-1.39
PEG (NY)N/A
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 1.73%
ROE 13.1%
ROCE 9.11%
ROIC 5.28%
ROICexc 5.3%
ROICexgc 10.99%
OM 6.6%
PM (TTM) 1.64%
GM 52.96%
FCFM 11.41%
ROA(3y)2.13%
ROA(5y)5.77%
ROE(3y)8.96%
ROE(5y)14.03%
ROIC(3y)5.36%
ROIC(5y)9.33%
ROICexc(3y)6.37%
ROICexc(5y)20.86%
ROICexgc(3y)19.79%
ROICexgc(5y)N/A
ROCE(3y)9.26%
ROCE(5y)16.11%
ROICexcg growth 3Y-36.82%
ROICexcg growth 5Y-31.29%
ROICexc growth 3Y-39.67%
ROICexc growth 5Y-14.21%
OM growth 3Y1.92%
OM growth 5Y7.99%
PM growth 3Y-30.96%
PM growth 5Y-8.74%
GM growth 3Y26.81%
GM growth 5Y20.74%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 4.51
Debt/FCF 5.87
Debt/EBITDA 3.82
Cap/Depr 15.94%
Cap/Sales 1.3%
Interest Coverage 1.83
Cash Conversion 86.18%
Profit Quality 695.95%
Current Ratio 1.75
Quick Ratio 0.37
Altman-Z 1.05
F-Score7
WACC5.65%
ROIC/WACC0.93
Cap/Depr(3y)14.65%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.16%
Cap/Sales(5y)N/A
Profit Quality(3y)385.01%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)500%
EPS 3Y12.55%
EPS 5Y50.47%
EPS Q2Q%-105.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.9%
Revenue growth 3Y80.47%
Revenue growth 5Y76.03%
Sales Q2Q%-6.75%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y19.26%
EBIT growth 3Y83.92%
EBIT growth 5Y90.1%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1777.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y402.73%
OCF growth 3YN/A
OCF growth 5YN/A